Vice President, Site & Patient Network, IQVIA
Pablo is the founder and CEO of Antidote. Since 2009, under his leadership, the company (formerly known as TrialReach) has raised almost $20m in venture capital and grown to become a leading player within the digital health sector, empowering thousands of patients worldwide to discover...
Read More →
